Masayuki Yamamoto Selected Research

Cytokines

10/2023	Nrf2 activation improves experimental rheumatoid arthritis.
8/2023	Association between low levels of anti-inflammatory cytokines during pregnancy and postpartum depression.
2/2023	The KEAP1-NRF2 system and neurodegenerative diseases.
1/2023	A rose flavor compound activating the NRF2 pathway in dendritic cells ameliorates contact hypersensitivity in mice.
1/2023	The KEAP1-NRF2 System and Neurodegenerative Diseases.
3/2022	Multifaceted Roles of the KEAP1-NRF2 System in Cancer and Inflammatory Disease Milieu.
1/2021	Genetic ablation of Nrf2 exacerbates neurotoxic effects of acrylamide in mice.
1/2020	Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma.
1/2019	Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
11/2017	Reducing Inflammatory Cytokine Production from Renal Collecting Duct Cells by Inhibiting GATA2 Ameliorates Acute Kidney Injury.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masayuki Yamamoto Research Topics

Disease

65	Neoplasms (Cancer) 11/2023 - 05/2002
55	Inflammation (Inflammations) 11/2023 - 01/2004
30	Hypoxia (Hypoxemia) 04/2024 - 02/2002
28	Anemia 04/2024 - 05/2003
28	Carcinogenesis 02/2024 - 02/2002
14	Fibrosis (Cirrhosis) 02/2021 - 08/2004
12	Lung Injury 10/2020 - 02/2002
11	Hyperoxia 01/2023 - 02/2002
11	Pneumonia (Pneumonitis) 12/2022 - 11/2004
10	Obesity 10/2021 - 10/2009
10	Starvation 01/2020 - 02/2007
9	Neoplasm Metastasis (Metastasis) 11/2016 - 04/2002
8	Body Weight (Weight, Body) 01/2024 - 01/2007
8	Acute Lung Injury 01/2023 - 06/2005
8	Insulin Resistance 01/2023 - 02/2008
8	Sickle Cell Anemia (Hemoglobin S Disease) 03/2022 - 07/2002
8	Atherosclerosis 01/2021 - 03/2004
8	Necrosis 01/2021 - 03/2006
7	Kidney Diseases (Kidney Disease) 04/2024 - 04/2011
7	Reperfusion Injury 01/2023 - 08/2009
7	Ischemia 01/2020 - 12/2007
6	Type 2 Diabetes Mellitus (MODY) 11/2023 - 04/2015
6	Chronic Renal Insufficiency 11/2023 - 09/2014
6	Breast Neoplasms (Breast Cancer) 12/2022 - 02/2002
6	Hypertension (High Blood Pressure) 01/2022 - 12/2005
6	Wounds and Injuries (Trauma) 01/2022 - 02/2003
6	Asthma (Bronchial Asthma) 11/2021 - 07/2005
5	Atrophy 01/2024 - 07/2004
5	Hyperplasia 08/2023 - 07/2005
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 05/2003
5	Lung Neoplasms (Lung Cancer) 02/2021 - 03/2006
5	Proteinuria 11/2019 - 10/2003
5	Hypersensitivity (Allergy) 10/2019 - 07/2005
5	Leukemia 01/2017 - 05/2007
5	Fatty Liver 02/2016 - 02/2010
5	Lung Diseases (Lung Disease) 02/2016 - 02/2009
5	Liver Diseases (Liver Disease) 06/2015 - 05/2007
5	Carcinoma (Carcinomatosis) 11/2014 - 09/2004
5	Emphysema 01/2009 - 11/2004
4	Infections 08/2023 - 05/2011
4	Hemolysis 06/2023 - 01/2005
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 01/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2020
4	Gallbladder Neoplasms (Gallbladder Cancer) 12/2019 - 05/2003
4	Stomach Neoplasms (Stomach Cancer) 11/2015 - 11/2002

Drug/Important Bio-Agent (IBA)

49	Transcription Factors (Transcription Factor)IBA 04/2024 - 02/2002
44	Proteins (Proteins, Gene)FDA Link 11/2022 - 09/2002
42	AntioxidantsIBA 11/2023 - 02/2002
30	EnzymesIBA 10/2023 - 02/2002
27	Erythropoietin FDA Link 04/2024 - 05/2002
22	CytokinesIBA 10/2023 - 05/2003
19	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2002
15	Messenger RNA (mRNA)IBA 11/2022 - 02/2002
11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2002
10	Glutathione (Reduced Glutathione)IBA 01/2024 - 02/2002
10	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2005
10	NF-E2-Related Factor 2IBA 01/2016 - 07/2007
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2009
9	Oxygen (Dioxygen)IBA 12/2021 - 02/2002
8	IronIBA 04/2024 - 07/2004
8	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 10/2023 - 01/2007
8	GlobinsIBA 11/2021 - 07/2002
8	Oxidants (Oxidizing Agents)IBA 01/2019 - 09/2002
8	sulforaphaneIBA 01/2019 - 09/2003
8	SmokeIBA 12/2018 - 11/2004
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010 - 07/2002
7	TriterpenesIBA 01/2023 - 01/2007
7	LipidsIBA 12/2022 - 01/2009
6	CarcinogensIBA 01/2023 - 09/2002
6	NitrogenIBA 12/2020 - 02/2007
6	Paclitaxel (Taxol)FDA LinkGeneric 12/2006 - 02/2002
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2024 - 02/2018
5	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 04/2024 - 01/2016
5	Kelch-Like ECH-Associated Protein 1IBA 10/2023 - 01/2016
5	Triglycerides (Triacylglycerol)IBA 12/2022 - 02/2003
5	Basic-Leucine Zipper Transcription FactorsIBA 01/2021 - 04/2006
5	Heme Oxygenase-1IBA 01/2021 - 02/2002
5	Blood Glucose (Blood Sugar)IBA 01/2020 - 08/2013
4	Indicators and Reagents (Reagents)IBA 04/2024 - 09/2008
4	Dimethyl FumarateIBA 02/2023 - 01/2018
4	ChemokinesIBA 02/2023 - 08/2009
4	AlbuminsIBA 02/2023 - 06/2005
4	CholesterolIBA 12/2022 - 07/2011
4	Urethane (Ethyl Carbamate)IBA 01/2022 - 01/2011
4	Interleukin-1beta (Interleukin 1 beta)IBA 01/2021 - 09/2003
4	8-Hydroxy-2'-DeoxyguanosineIBA 02/2020 - 11/2004
4	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2020 - 03/2014
4	GATA Transcription FactorsIBA 08/2019 - 05/2007
4	Heme (Haem)IBA 01/2019 - 06/2006
4	Bleomycin (Blenoxane)FDA LinkGeneric 03/2017 - 08/2004
4	Insulin (Novolin)FDA Link 01/2017 - 08/2014
4	Uridine Diphosphate (UDP)IBA 01/2017 - 02/2002
4	XenobioticsIBA 01/2016 - 02/2007
4	Interleukin-6 (Interleukin 6)IBA 10/2015 - 07/2002

Therapy/Procedure

29	Therapeutics 11/2023 - 02/2002
11	Drug Therapy (Chemotherapy) 12/2022 - 10/2003
6	Oral Administration 01/2024 - 12/2004
5	Chemoprevention 01/2016 - 09/2002
4	Lymph Node Excision (Lymph Node Dissection) 12/2019 - 11/2015